Browse

Protein Engineering of Heat shock 27 and Neprilysin for therapeutic application to Alzheimer's disease

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors
최성현
Advisor
박종상
Major
자연과학대학 화학부
Issue Date
2015-08
Publisher
서울대학교 대학원
Keywords
protein therapy
Description
학위논문 (박사)-- 서울대학교 대학원 : 화학부 생화학전공, 2015. 8. 박종상.
Abstract
Alzheimers disease (AD) is a progressive neurodegenerative disorder with neurofibrillary tangles (NFTs) and amyloid-beta (Aβ) plaques. The tau is a
major component of NFTs, a microtubule-associated protein. In AD, tau is abnormally aggregated and hyperphosphorylated into NFTs in neurons. The
pathological tau proteins lose the capability to rescue microtubules in transporting neuronal substance, leading to neuronal dysfunction and apoptosis. Phosphorylated tau would have a ubiquitin-independent pathway
that can be facilitated by Hsp27 mechanism leading to its dephosphorylation or degradation. The cytoprotective effects of Hsp27 include its role as a molecular chaperone, the inhibition of caspase activation, the prevention of
stress-induced disruption of the cytoskeleton, and modulation of the intracellular redox potential. I generated a fusion protein of Hsp27 and the protein transduction domain of the HIV Tat protein (Tat-Hsp27) to enhance the delivery of Hsp27 into cells. the recombinant Tat-Hsp27 reduced the
level of hyperphosphorylated tau induced by okadaic acid in SH-SY5Y neuroblastoma cells and prevented the apoptosis induced by abnormal tau aggregates in our cellular model of AD. Aβ is derived from amyloid precursor protein (APP) by β-secretase and γ-secretase. Aβ is immediately catabolized under normal conditions, whereas
dysmetabolism of Aβ seems to lead to pathological deposition upon aging. Neprilysin (NEP) is a rate-limiting peptidase involved in the physiological
degradation of Aβ in the brain. Thus, the reduction of neprilysin activity will contribute to Aβ accumulation and consequently to AD development. NEP is a type II membrane metalloendopeptidase with an active site
containing a zinc-binding motif at the extracellular carboxyl terminal domain and exists on plasma membrane as a noncovalently associated homodimer. I designed a gene encoding the extracellular domain (52?750) of human NEP. Recombinant soluble human NEP was secreted from insect
cells transduced with baculovirus expressing the extracellular domain and purified by affinity chromatography on a histrap column and size exclusion
chromatography on a superdex 200 column. The purified NEP could reduce a decrease of Aβ-mediated apoptosis of hippocampal cells and increase cell viability in vitro. The number of Aβ plaques and memory impairment was
diminished by the presence of recombinant soluble neprilysin in the brain of AD model mice. These findings suggest that recombinant Tat-Hsp27 and soluble human neprilysin are a promising candidates as therapeutic protein
for Alzheimers disease.
Language
Korean
URI
https://hdl.handle.net/10371/125287
Files in This Item:
Appears in Collections:
College of Natural Sciences (자연과학대학)Dept. of Chemistry (화학부)Theses (Ph.D. / Sc.D._화학부)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse